Advanced search
Publication Cover
Future Oncology Volume 19, 2023 - Issue 36
Submit an article Journal homepage
141
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Sintilimab Plus Fluorouracil, Leucovorin, Oxaliplatin and Docetaxel Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer and Biomarker Exploration

Jiangpeng Wei1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,China
,
Xin Guo1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,China
,
Xisheng Yang1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,China
,
Jinqiang Liu1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,China
,
Qianqian Duan2 The State Key Lab of Translational Medicine & Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing,China
,
Yuan Tan2 The State Key Lab of Translational Medicine & Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing,China
,
Qin Zhang2 The State Key Lab of Translational Medicine & Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing,China
,
Tingting Sun2 The State Key Lab of Translational Medicine & Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing,China
,
Chuang Qi2 The State Key Lab of Translational Medicine & Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing,China
,
Xiaohua Li1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,ChinaCorrespondence[email protected]
&
Gang Ji1 Department of Gastrointestinal Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an,Shaanxi,ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0008-5089-5603
ORCID Icon show all
Pages 2395-2403 | Received 19 Sep 2023, Accepted 26 Oct 2023, Published online: 22 Nov 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.